Intas Pharmaceuticals
Suyash Sharma is a biotechnology professional with extensive experience in the pharmaceutical industry. Currently serving as a Senior Executive at Intas Pharmaceuticals since June 2024, Suyash previously held the position of Executive at Biocon Biologics from December 2022 to June 2024 and at Intas Pharmaceuticals from December 2020 to December 2022, focusing on the manufacturing of plasma-derived products. Earlier, Suyash worked as a Trainee Scientific Officer at Panacea Biotec, gaining hands-on experience in production operations for HBsAg vaccines. Suyash holds a Master's degree in Biotechnology from SRM IST Chennai and a Bachelor's degree in Biotechnology from Meerut Institute of Engineering and Technology, complemented by research experience in combined toxicity studies during academic training.
This person is not in the org chart
Intas Pharmaceuticals
2 followers
Intas Pharmaceuticals Ltd. is an India-based pharmaceutical formulation development, manufacturing and marketing company. The Company offers products for the treatment of cardiovascular system (CVS), diabetology, gynecology, infertility, respiratory care, gastroenterology, pain management, as well as other therapeutic segments. Its pharma products include ACUTROL-400, ADAPEN GEL, ADIFLOX, ALZIL 10, ALZIL M 10 and AMITONE 10. The Company's biologics products include Albucel 20%, Epofit, Erykine, Factocel VIII, MabTas, Neukine and Neupeg. It range of products for animal health includes AC-Vet, AC-Vet Forte, AC-Vet Max, Alzonic, Anistamin, Benezepril, Bufzone, Calshakti Platina and Carprofen Inj. The Company offers approximately 10 biologic products and is engaged in research and development in chronic disease areas, such as oncology (cancer), rheumatology, auto-immune, nephrology, ophthalmology and plasma derived product based therapies.